Konjac petroleum ether extract inhibits triple-negative breast cancer cell migration and invasion by attenuating

Yian Chen1, Qinghong Yu1, Haining Ding1

  • 1The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.

Abstract

Insights

Konjac extract inhibits triple-negative breast cancer (TNBC) cell migration and invasion by modulating OLFML2A to suppress epithelial-mesenchymal transition (EMT). This suggests konjac extract

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Triple-negative breast cancer (TNBC) is an aggressive subtype with limited treatment options.
  • Epithelial-mesenchymal transition (EMT) is a key process in cancer metastasis.
  • The OLFML2A gene's role in TNBC progression is under investigation.

Purpose of the Study:

  • To investigate the inhibitory effect of konjac petroleum ether extract on TNBC cell migration, invasion, and EMT.
  • To elucidate the mechanism of action involving the OLFML2A gene.
  • To assess the potential of konjac extract as a therapeutic agent for TNBC.

Main Methods:

  • Analysis of OLFML2A expression and EMT markers in TNBC patient specimens.
  • Gene knockdown of OLFML2A in MDA-MB-231 cells.
  • Treatment of OLFML2A-knockdown cells with konjac petroleum ether extract.
  • Evaluation of cell migration, invasion, adhesion, and EMT marker expression using qPCR, Western blot, and immunofluorescence.

Main Results:

  • High OLFML2A expression correlated with reduced E-cadherin and increased N-cadherin, vimentin, and elastin in TNBC patients.
  • OLFML2A knockdown in MDA-MB-231 cells reduced migration and invasion, upregulating E-cadherin and downregulating mesenchymal markers.
  • Konjac extract inhibited TNBC cell proliferation (IC50 = 220 μg/mL at 48h) and dose-dependently inhibited migration and invasion.
  • Konjac extract mimicked the effects of OLFML2A knockdown on EMT markers.

Conclusions:

  • Konjac petroleum ether extract inhibits TNBC cell migration and invasion by modulating OLFML2A to inhibit EMT.
  • These findings suggest konjac extract's potential for preventing TNBC metastasis.
  • Further investigation is needed to understand the contribution of cytotoxicity at higher concentrations.